Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Platelet-Rich Plasma vs Corticosteroid Injection in Rotator Cuff Tendinopathy
NCT05603468Phase 4Active, not recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2022
- Primary completion
- Dec 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 4 trial of autologous platelet-rich plasma in rotator cuff tendinopathy (RCT), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Dec 2022; status: active, not recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
rotator cuff tendinopathy (RCT)
Beyond the preview
Go deeper on NCT05603468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05603468.